Published

The subtle science: a systematic review of psilocybin magic mushroom and truffle microdosing

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Frontiers in Psychiatry
Date: 2026-08-19
Source: Crossref
DOI: 10.3389/fpsyt.2026.1866881
PubMed: Unavailable

Authors

Page Jeni Moore Alexandra Hawkins Bridget E.Lyons Elizabeth J.Lorenzo Elizabeth

Watch author

Derived topics and classifications

psilocybin Chronic Pain Microdosing Wellbeing Creativity Randomized Controlled Trial Systematic Review Review Article Safety Adverse Events Randomized Controlled Trial

Citation graph

40 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

10.1016/j.forsciint.2003.08.009 10.1002/dta.1400 10.1016/j.jad.2025.120882 10.1007/s00213-025-06788-w 10.1177/02698811241312866 10.3389/fpsyt.2024.1416420 10.1136/bmj-2023-078084 10.1080/13803395.2024.2363343 10.1111/pcn.13741 10.1080/02791072.2022.2044096 10.1016/j.neubiorev.2022.104706 10.1177/0269881119857204

Indexed papers citing this DOI

The subtle science: a systematic review of psilocybin magic mushroom and truffle microdosing2026-08-19

Related papers

Microdosing Psilocybin for Major Depressive Disorder: Study Protocol for a Phase II Double-Blind Placebo-Controlled Randomized Partial Crossover TrialPsyArXiv · 2025-11-16 The effect of psychedelic microdosing on animal behavior: A review with recommendations for the field.Neuroscience and biobehavioral reviews · 2025-07-01 Preliminary safety and effectiveness of psilocybin-assisted therapy in adults with fibromyalgia: An open-label, pilot clinical trialPsyArXiv · 2024-11-04 Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life-threatening diseases.The Cochrane database of systematic reviews · 2024-09-12 Publication bias in randomized trials of psilocybin for depression: a Robust Bayesian Meta-AnalysisPsyArXiv · 2026-07-17 Altered States, Enhanced Potential: Psychedelics and Physical PerformancePsyArXiv · 2026-06-12 Low doses of psilocybin as adjunct pharmacological treatment to virtual reality exposure therapy for social anxiety disorder: A study protocol for a double-blind randomized controlled trial.PsyArXiv · 2026-05-14 Safety and Efficacy of Psilocybin-Assisted Therapy for Alcohol Use Disorder: Open-Label Extension of a Phase II Randomized Controlled TrialPsyArXiv · 2026-03-26